These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17267340)

  • 21. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study.
    Oh WS; Suh JY; Song JH; Ko KS; Jung SI; Peck KR; Lee NY; Yang Y; Chongthaleong A; Chiu CH; Kamarulzaman A; Parasakthi N; Lalitha MK; Perera J; Yee TT; Kumarasinghe G; Carlos CC;
    Microb Drug Resist; 2004; 10(1):37-42. PubMed ID: 15140392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
    Balsalobre L; de la Campa AG
    Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones].
    Malakhova MV; Vereshchagin VA; Il'ina EN; Govorun VM; Filimonova OIu; Grudinina SA; Sidorenko SV
    Antibiot Khimioter; 2007; 52(1-2):10-7. PubMed ID: 18461803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
    Sierra JM; Cabeza JG; Ruiz Chaler M; Montero T; Hernandez J; Mensa J; Llagostera M; Vila J
    Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoroquinolone resistance in Streptococcus pneumoniae from a university hospital, Thailand.
    Srifuengfung S; Tribuddharat C; Chokephaibulkit K; Comerungsee S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S35-9. PubMed ID: 21298832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections].
    Suzuki K; Kurono Y; Kobayashi T; Nishimura T; Baba S; Harabuchi Y; Fujisawa T; Yamanaka N; Ubukata K; Ikeda F
    Jpn J Antibiot; 2010 Aug; 63(4):312-8. PubMed ID: 21298864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
    Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
    J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
    Schafer J; Hovde LB; Simonson D; Rotschafer JC
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
    Kim JM; Kim JS; Kim N; Jung HC; Song IS
    J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
    LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).
    Ceyssens PJ; Van Bambeke F; Mattheus W; Bertrand S; Fux F; Van Bossuyt E; Damée S; Nyssen HJ; De Craeye S; Verhaegen J; ; Tulkens PM; Vanhoof R
    PLoS One; 2016; 11(5):e0154816. PubMed ID: 27227336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I; Kay E; Schneider D; Maurin M
    J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.
    Sun HK; Du X; DeRyke CA; Doern GV; Nicolau DP
    Int J Antimicrob Agents; 2007 Feb; 29(2):230-2. PubMed ID: 17204405
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.
    De Vecchi E; Nicola L; Ossola F; Drago L
    J Antimicrob Chemother; 2009 Apr; 63(4):721-7. PubMed ID: 19218275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.
    Davies TA; Yee YC; Bush K; Sahm D; Evangelista A; Goldschmidt R
    Microb Drug Resist; 2008 Sep; 14(3):187-96. PubMed ID: 18707553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.